Nakopoulou L L, Constandinides C A, Tzonou A, Lazaris A C, Zervas A, Dimopoulos C A
Department of Pathology, Medical School of Athens University, Greece.
Histopathology. 1996 May;28(5):429-35. doi: 10.1046/j.1365-2559.1996.336375.x.
The expression of the nm23-H1 gene has been suggested to have an inverse association with metastases in certain tumours. The aim of this study was to investigate the relationship of nm23-H1 immunohistochemical expression with pathological tumour variables and survival in a series of transitional cell carcinomas (TCCs) of the bladder. Formalin-fixed, paraffin-embedded archival tissue from 87 carcinomas (Ta-T1 45 cases) and T2-T4 (42 cases) was immunostained (Strept ABC/HRP) with the NDPK-A monoclonal antibody (NDPK-A) against nm23-H1 protein. The tumours had already been evaluated for immuno-expression of p53 protein. In addition, DNA analysis was performed by flow cytometry. Results were analysed using the linear trend in proportions test, the Fisher's exact test and multivariate analysis. Paradoxically, advanced tumour stage showed significant correlation with nm23-H1 immunopositivity in muscle invasive TCCs (P(t) = 0.01). Patients with nm23-H1 positive, muscle invasive TCCs had a worse prognosis at a level of suggestive statistical significance (PF = 0.08). In multivariate analysis, using a Cox's proportional hazards survival model with six variables, tumour grade, disease stage and synchronous p53 and nm23-H1 detection showed significant correlation with poor patient survival (P = 0.014, P = 0.049 and P = 0.05, respectively).
研究表明,nm23-H1基因的表达与某些肿瘤的转移呈负相关。本研究旨在探讨nm23-H1免疫组化表达与一系列膀胱移行细胞癌(TCC)的病理肿瘤变量及生存率之间的关系。用抗nm23-H1蛋白的NDPK-A单克隆抗体(NDPK-A)对87例癌(Ta-T1期45例,T2-T4期42例)的福尔马林固定、石蜡包埋存档组织进行免疫染色(链霉抗生物素蛋白-生物素复合物/辣根过氧化物酶法)。这些肿瘤已经过p53蛋白免疫表达的评估。此外,通过流式细胞术进行DNA分析。采用比例检验的线性趋势、Fisher精确检验和多变量分析对结果进行分析。矛盾的是,在肌肉浸润性TCC中,肿瘤晚期与nm23-H1免疫阳性呈显著相关(P(t)=0.01)。nm23-H1阳性的肌肉浸润性TCC患者预后较差,具有统计学意义(PF=0.08)。在多变量分析中,使用具有六个变量的Cox比例风险生存模型,肿瘤分级、疾病分期以及同步检测p53和nm23-H1与患者生存率低显著相关(分别为P = 0.014、P = 0.049和P = 0.05)。